Kazufumi Nakamura

Kazufumi Nakamura currently serves as Investment Director and Venture Partner at Mitsui & Co. Global Investment, Inc., with a tenure beginning in June 2017. In addition to this role, Kazufumi is actively involved in various companies as a Board Observer for Reunion Neuroscience, Mahzi Therapeutics, and NVasc, and as an Investor at Ensem Therapeutics. Kazufumi also holds the position of Board Observer at BioNova Pharmaceuticals Ltd and has been with Japan Innovative Therapeutics as Director of Business Development since October 2015. Prior to these roles, Kazufumi was Senior Manager in the Venture Capital Business Department of Mitsui & Co., Ltd., and held positions in Global Business Development at Santen Pharmaceutical and Portfolio Management & Clinical Planning at The Janssen Pharmaceutical Companies of Johnson & Johnson.